liu.seSearch for publications in DiVA
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Tyrosine kinase inhibitor therapy-induced changes in humoral immunity in patients with chronic myeloid leukemia
University of Helsinki, Finland; Helsinki University Hospital, Finland.
University of Helsinki, Finland; Helsinki University Hospital, Finland.
University of Helsinki, Finland; Helsinki University Hospital, Finland.
University of Helsinki, Finland; Helsinki University Hospital, Finland.
Vise andre og tillknytning
2017 (engelsk)Inngår i: Journal of Cancer Research and Clinical Oncology, ISSN 0171-5216, E-ISSN 1432-1335, Vol. 143, nr 8, s. 1543-1554Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Purpose Tyrosine kinase inhibitors (TKIs) have well-characterized immunomodulatory effects on T and NK cells, but the effects on the humoral immunity are less well known. In this project, we studied TKI-induced changes in B cell-mediated immunity. Methods We collected peripheral blood (PB) and bone marrow (BM) samples from chronic myeloid leukemia (CML) patients before and during first-line imatinib (n = 20), dasatinib (n = 16), nilotinib (n = 8), and bosutinib (n = 12) treatment. Plasma immunoglobulin levels were measured, and different B cell populations in PB and BM were analyzed with flow cytometry. Results Imatinib treatment decreased plasma IgA and IgG levels, while dasatinib reduced IgM levels. At diagnosis, the proportion of patients with IgA, IgG, and IgM levels below the lower limit of normal (LLN) was 0, 11, and 6% of all CML patients, respectively, whereas at 12 months timepoint the proportions were 6% (p = 0.13), 31% (p = 0.042) and 28% (p = 0.0078). Lower initial Ig levels predisposed to the development of hypogammaglobulinemia during TKI therapy. Decreased Ig levels in imatinibtreated patients were associated with higher percentages of immature BM B cells. The patients, who had low Ig levels during the TKI therapy, had significantly more frequent minor infections during the follow-up compared with the patients with normal Ig values (33% vs. 3%, p = 0.0016). No severe infections were reported, except recurrent upper respiratory tract infections in one imatinib-treated patient, who developed severe hypogammaglobulinemia. Conclusions TKI treatment decreases plasma Ig levels, which should be measured in patients with recurrent infections.

sted, utgiver, år, opplag, sider
Springer, 2017. Vol. 143, nr 8, s. 1543-1554
Emneord [en]
CML; Tyrosine kinase inhibitor; B cell; Immunoglobulin
HSV kategori
Identifikatorer
URN: urn:nbn:se:liu:diva-139536DOI: 10.1007/s00432-017-2378-6ISI: 000405312900015PubMedID: 28337541Scopus ID: 2-s2.0-85015969804OAI: oai:DiVA.org:liu-139536DiVA, id: diva2:1130072
Merknad

Funding Agencies|Academy of Finland; Finnish Cancer Societies; Sigrid Juselius Foundation; Finnish Cancer Institute; Signe and Ane Gyllenberg Foundation; Otto A. Malm Foundation; EUTOS project for CML; Pfizer; Novartis; Bristol-Myers Squibb [NordCML006, NordCML007]

Tilgjengelig fra: 2017-08-08 Laget: 2017-08-08 Sist oppdatert: 2018-04-18bibliografisk kontrollert

Open Access i DiVA

Fulltekst mangler i DiVA

Andre lenker

Forlagets fulltekstPubMedScopus

Personposter BETA

Lotfi, Kourosh

Søk i DiVA

Av forfatter/redaktør
Lotfi, Kourosh
Av organisasjonen
I samme tidsskrift
Journal of Cancer Research and Clinical Oncology

Søk utenfor DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 92 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf